CurrentRheuma
Get Weekly

Topic · page 26 of 26

Spondyloarthritis & psoriatic arthritis

Axial spondyloarthritis (radiographic and non-radiographic), peripheral spondyloarthritis, psoriatic arthritis and psoriatic disease studied across joints and skin, enthesitis and dactylitis, arthritis with inflammatory bowel disease, reactive arthritis, uveitis in spondyloarthritis, imaging of the sacroiliac joints and spine

Briefs 1,001–1,039 of 1,039 placed here, newest publication first

Briefs in Spondyloarthritis & psoriatic arthritis

Newest publication first

  1. Rheumatology (Oxford)

    Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort

    Diagnostic or prognostic study

  2. J Rheumatol

    The Sensitivity to Change of the ASAS Health Index in an Observational Real-Life Cohort Study

    Cohort study

  3. Rheumatology (Oxford)

    Association between psoriatic disease and lifestyle factors and comorbidities: cross-sectional analysis and Mendelian randomization

    Cross-sectional study

  4. J Rheumatol

    Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis

    Diagnostic or prognostic study

  5. Rheumatology (Oxford)

    Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1

    Secondary analysis

  6. Rheumatology (Oxford)

    Disease-specific expansion of CD29+IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis

    Mechanistic study

  7. Rheumatology (Oxford)

    Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE

    Randomized controlled trial

  8. Rheumatology (Oxford)

    Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation

    Diagnostic or prognostic study

  9. J Rheumatol

    Inflammatory Bowel Disease Risk in Patients With Axial Spondyloarthritis Treated With Biologic Agents Determined Using the BSRBR-AS and a MetaAnalysis

    Meta-analysis

  10. Rheumatology (Oxford)

    Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis

    Meta-analysis

  11. Clin Exp Rheumatol

    Equivalent cut-off values of Bath Ankylosing Spondylitis Disease Activity Index corresponding to Ankylosing Spondylitis Disease Activity Score cut-off values

    Diagnostic or prognostic study

  12. Clin Exp Rheumatol

    Associations between family history of psoriatic disease and clinical characteristics on patients with psoriatic arthritis: a nationwide study from the Chinese Registry of Psoriatic Arthritis (CREPAR II)

    Cross-sectional study

  13. Rheumatology (Oxford)

    Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

    Cohort study

  14. Rheumatology (Oxford)

    Non-invasive metabolic profiling of inflammation in joints and entheses by multispectral optoacoustic tomography

    Cross-sectional study

  15. Scand J Rheumatol

    How good is the agreement between clinical diagnoses and classification criteria fulfilment in axial spondyloarthritis? Results from the SPARTAKUS cohort

    Cross-sectional study

  16. Ann Rheum Dis

    Instrument selection for the ASAS core outcome set for axial spondyloarthritis

    Guideline or statement

  17. Scand J Rheumatol

    Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register

    Diagnostic or prognostic study

  18. Clin Exp Rheumatol

    The faecal microbiota is distinct in HLA-B27+ ankylosing spondylitis patients versus HLA-B27+ healthy controls

    Cross-sectional study

  19. Scand J Rheumatol

    Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial

    Randomized controlled trial

  20. Rheumatology (Oxford)

    Anatomical variation of the sacroiliac joint carries an increased risk for erosion and bone marrow oedema in axial spondyloarthritis

    Cross-sectional study

  21. Rheumatology (Oxford)

    Strong site-specific association of pharyngeal cultures with the onset of psoriatic arthritis and psoriasis, regardless of pathogen

    Cohort study

  22. Clin Exp Rheumatol

    Machine-learning derived algorithms for prediction of radiographic progression in early axial spondyloarthritis

    Cohort study

  23. Clin Exp Rheumatol

    The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis

    Cross-sectional study

  24. Scand J Rheumatol

    Increased prevalence of sleep disturbance in psoriatic arthritis is associated with inflammatory and non-inflammatory measures

    Cross-sectional study

  25. Clin Exp Rheumatol

    Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort

    Cohort study

  26. Clin Exp Rheumatol

    Confounders contributing to explain the association between sex and disease impact in patients with recent-onset psoriatic arthritis

    Cohort study

  27. Clin Exp Rheumatol

    Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients' perception?

    Cohort study

  28. Clin Exp Rheumatol

    Anti-SARS-CoV-2 antibody decay after vaccination and immunogenicity of the booster dose of the BNT162b2 mRNA vaccine in patients with psoriatic arthritis on TNF inhibitors

    Cohort study

  29. Clin Exp Rheumatol

    Response to netakimab in radiographic axial spondyloarthritis patients with different baseline C-reactive protein, sacroiliitis evaluated by MRI and peripheral joint involvement status: a post-hoc analysis of the ASTERA study

    Secondary analysis

  30. Clin Exp Rheumatol

    Persistence of remission after lengthening of golimumab in inflammatory joint diseases

    Cohort study

  31. J Rheumatol

    Doppler Signal and Bone Erosions at the Enthesis Are Independently Associated With Ultrasound Joint Erosive Damage in Psoriatic Arthritis

    Cross-sectional study

  32. Clin Exp Rheumatol

    Efficacy of secukinumab on dactylitis in patients with active psoriatic arthritis from the FUTURE 5 study

    Secondary analysis

  33. Scand J Rheumatol

    Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy

    Cross-sectional study

  34. Clin Exp Rheumatol

    Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers

    Cross-sectional study

  35. Clin Exp Rheumatol

    Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors

    Cohort study

  36. Clin Exp Rheumatol

    Impact of psoriasis remains important in psoriatic arthritis patients with low musculoskeletal disease activity

    Cohort study

  37. Clin Exp Rheumatol

    Association of circulating lymphocyte subsets with response to IL17i and TNFi in axial spondyloarthritis

    Cohort study

  38. Clin Exp Rheumatol

    Clinical and laboratory factors associated with the bamboo spine in patients with axial spondyloarthritis: are there clues for the bamboo spine?

    Cross-sectional study

  39. Scand J Rheumatol

    Implementing enhancements in supervised group exercise for people with axial spondyloarthritis: a hybrid effectiveness–implementation study

    Research article

All 1,039 Briefs in ExploreShowing Briefs 1,001–1,039 of 1,039, newest first